Michael Staehler
@MichaelStaehler
Followers
847
Following
11K
Media
187
Statuses
2K
RT @neerajaiims: Just came online in @TheLancet 👉Our two papers on improved OS with Enzalutamide + Talazoparib in mCRPC #ProstateCancer in….
0
60
0
RT @kcCURE: 📣 Live at #ASCO25: Learn from real-world #RCC cases with @montypal, Dr. McDermott & @TiansterZhang. ✅ IO-based regimens. ✅ Sequ….
lrn.peerview.com
See a new #renalcellcarcinoma activity via @PeerView @montypal @uromigos @tiansterzhang #ASCO25 #Oncology #MedEd
0
13
0
RT @TiansterZhang: Just a week away! .Please join us in Chicago at this Peerview event, 7pm central on Sat 5/31! .Register here:. https://t.….
lrn.peerview.com
See the latest #RenalCellCarcinoma live event from @PeerView @montypal #ASCO25 #MedEd
0
18
0
RT @salvolarosa: Great job @KidneyCancerJ! Do not miss all the research articles from Linnea Olsson, @MichaelStaehler @LauraBukavinaMD Davi….
0
4
0
RT @TiansterZhang: Congratulations @MichaelStaehler, recipient of #FitzgeraldAward @KidneyCancer #IKCSEU25! Legacy and innovation. Sets cha….
0
8
0
RT @KidneyCancer: Good morning everyone, #IKCSEU25 begins TODAY 🎊 🎉 . We are excited to come together here in Amsterdam talk about the futu….
0
3
0
RT @KidneyCancer: 🎉CONGRATULATIONS to @MichaelStaehler, recipient of the KCA's 2025 John Fitzpatrick Award recognizing excellence in urolog….
0
7
0
RT @KidneyCancer: One day left for early registration to attend the 2025 IKCS: Europe! #IKCSEU25.See you in Amsterdam, May 1-3 for an excit….
kidneycancer.org
Transforming Kidney Cancer Research The Kidney Cancer Association is proud to host the 2025 International Kidney Cancer Symposium (IKCS): Europe. IKCS meetings are dynamic, multidisciplinary events...
0
2
0
RT @DrDamluji: Global Effect of Cardiovascular Risk Factors on Lifetime Estimates: @NEJM . 🥸 Great work from Germany on global life time ri….
0
116
0
RT @RCCadvocate: 70% of health-related internet searches are zero-click - which means pts are relying on snippets and AI overviews for info….
0
14
0
RT @kcCURE: Clear cell RCC is heterogeneous. @utswcancer’s @TiansterZhang presents the new frontier and dares us to imagine patients unique….
0
15
0
RT @BraunMDPhD: @TiansterZhang with masterful discussion of kry presentations from @AlbigesL @motzermd @katy_beckermann #GU24
https://t.co/….
0
9
0
RT @OncoAlert: Great Poster by our friends at @kcCURE at #GU25 Spoke to First Author Dena Blattle @RCCadvocate who tells us more:. Disease….
0
22
0
RT @OncLive: Burden of mRCC – Insights from KCCure survey.🛑 36% visited the ER, 23% hospitalized, 44% spend hours daily thinking about canc….
0
7
0
RT @kcCURE: #GU35 44% of #kidneycancer pts spend HOURS thinking about cancer. In last 90 days, 36% have gone to ER. >1/3 of patients say th….
0
19
0
RT @salvolarosa: @RCCadvocate presenting at @pfizer advocacy breakfast at #GU25 on disease burden. Such important reminder to balance betwe….
0
2
0
RT @RCCadvocate: #kidneycancer Patients want to be cured. They will accept treatments that increase survival - but they want cure. Thanks @….
curetoday.com
Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
0
4
0